MARKET

TBPH

TBPH

Theravance Bioph
NASDAQ
11.39
-0.07
-0.61%
Opening 12:51 07/11 EDT
OPEN
11.41
PREV CLOSE
11.46
HIGH
11.41
LOW
11.27
VOLUME
23.61K
TURNOVER
--
52 WEEK HIGH
11.82
52 WEEK LOW
7.44
MARKET CAP
569.52M
P/E (TTM)
-9.6037
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at TBPH last week (0630-0704)?
Weekly Report · 4d ago
Weekly Report: what happened at TBPH last week (0623-0627)?
Weekly Report · 06/30 11:51
Theravance Biopharma Is Maintained at Buy by BTIG
Dow Jones · 06/27 15:08
BTIG Maintains Buy on Theravance Biopharma, Raises Price Target to $25
Benzinga · 06/27 14:58
BTIG Sticks to Their Buy Rating for Theravance Biopharma (TBPH)
TipRanks · 06/26 23:25
Theravance Biopharma (TBPH) Gets a Buy from JonesTrading
TipRanks · 06/26 15:45
Theravance higher as China approves Viatris-partnered COPD therapy
Seeking Alpha · 06/26 11:04
Theravance To Receive Milestone Payment From Viatris For Regulatory Approval Of YUPELRI In China
NASDAQ · 06/26 10:48
More
About TBPH
Theravance Biopharma, Inc. is a biopharmaceutical company primarily focused on the development and commercialization of medicines for the specialty respiratory and neurologic diseases. The Company operates through a single segment, namely, development and commercialization of human therapeutics. Its product, YUPELRI (revefenacin) inhalation solution, is a nebulized long-acting muscarinic antagonist used for the treatment of patients with chronic obstructive pulmonary disease (COPD). COPD is a long-term lung disease that includes chronic bronchitis, emphysema, or both. YUPELRI is an anticholinergic medicine, which helps the muscles around the airway in the lungs stay relaxed to prevent symptoms, such as wheezing, shortness of breath, and others. Its Ampreloxetine, is a late-stage investigational norepinephrine reuptake inhibitor in development for the treatment of symptomatic neurogenic orthostatic hypotension in patients with Multiple System Atrophy.

Webull offers Theravance Biopharma Inc stock information, including NASDAQ: TBPH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TBPH stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TBPH stock methods without spending real money on the virtual paper trading platform.